Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: Expression associated with human lymphoma malignancy

Journal of Leukocyte Biology

Volumn 94, Issue 4, 2013, Pages 779-789

  Vallejo Gracia, Albert ^a   Bielanska, Joanna ^a   Hernández Losa, Javier ^b   Castellví, Josep ^b   Ruiz Marcellan, M Carmen ^b   Ramón y Cajal, Santiago ^b   Condom, Enric ^c   Manils, Joan ^c   Soler, Concepció ^c   Comes, Núria ^a   Ferreres, Joan Carles ^b   Felipe, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

B cell; Cancer; Migration; Potassium channels; Proliferation

Indexed keywords

POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5;

ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

B CELL; CANCER; MIGRATION; POTASSIUM CHANNELS; PROLIFERATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; KV1.3 POTASSIUM CHANNEL; KV1.5 POTASSIUM CHANNEL; LYMPH NODES; LYMPHOMA; MICE; MIDDLE AGED; PHENOTYPE; RNA, MESSENGER; YOUNG ADULT;

EID: 84884854283     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0213094     Document Type: Article

References (48)

1. Cahalan, M. D., Chandy, K. G. (2009) The functional network of ion channels in T lymphocytes. Immunol. Rev. 231, 59-87.
2. Beeton, C., Chandy, K. G. (2005) Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 11, 550-562.
3. Rangaraju, S., Chi, V., Pennington, M. W., Chandy, K. G. (2009) Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin. Ther. Targets 13, 909-924.
4. Vicente, R., Escalada, A., Coma, M., Fuster, G., Sanchez-Tillo, E., Lopez-Iglesias, C., Soler, C., Solsona, C., Celada, A., Felipe, A. (2003) Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J. Biol. Chem. 278, 46307-46320.
5. Vicente, R., Escalada, A., Villalonga, N., Texido, L., Roura-Ferrer, M., Martin-Satue, M., Lopez-Iglesias, C., Soler, C., Solsona, C., Tamkun, M. M., Felipe, A. (2006) Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J. Biol. Chem. 281, 37675-37685.
6. Villalonga, N., David, M., Bielanska, J., Vicente, R., Comes, N., Valenzuela, C., Felipe, A. (2010) Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J. Gen. Physiol. 135, 135-147.
7. Zsiros, E., Kis-Toth, K., Hajdu, P., Gaspar, R., Bielanska, J., Felipe, A., Rajnavolgyi, E., Panyi, G. (2009) Developmental switch of the expression of ion channels in human dendritic cells. J. Immunol. 183, 4483-4492.
8. Villalonga, N., David, M., Bielanska, J., Gonzalez, T., Parra, D., Soler, C., Comes, N., Valenzuela, C., Felipe, A. (2010) Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels. Biochem. Pharmacol. 80, 858-866.
9. Villalonga, N., Escalada, A., Vicente, R., Sanchez-Tillo, E., Celada, A., Solsona, C., Felipe, A. (2007) Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem. Biophys. Res. Commun. 352, 913-918.
10. Monroe, J. G., Cambier, J. C. (1983) B cell activation. I. Anti-immunoglobulin-induced receptor cross-linking results in a decrease in the plasma membrane potential of murine B lymphocytes. J. Exp. Med. 157, 2073-2086.
11. Kotecha, S. A., Schlichter, L. C. (1999) A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J. Neurosci. 19, 10680-10693.
12. Gollapudi, S. V., Vayuvegula, B. S., Thadepalli, H., Gupta, S. (1988) Effect of K+ channel blockers on anti-immunoglobulin-induced murine B cell proliferation. J. Clin. Lab. Immunol. 27, 121-125.
13. Amigorena, S., Choquet, D., Teillaud, J. L., Korn, H., Fridman, W. H. (1990) Ion channels and B cell mitogenesis. Mol. Immunol. 27, 1259-1268.
14. Partiseti, M., Korn, H., Choquet, D. (1993) Pattern of potassium channel expression in proliferating B lymphocytes depends upon the mode of activation. J. Immunol. 151, 2462-2470.
15. Freedman, B. D., Price, M. A., Deutsch, C. J. (1992) Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes. J. Immunol. 149, 3784-3794.
16. Levitan, E. S., Gealy, R., Trimmer, J. S., Takimoto, K. (1995) Membrane depolarization inhibits Kv1.5 voltage-gated K+ channel gene transcription and protein expression in pituitary cells. J. Biol. Chem. 270, 6036-6041.
17. McCann, F. V., McCarthy, D. C., Noelle, R. J. (1990) Patch-clamp profile of ion channels in resting murine B lymphocytes. J. Membr. Biol. 114, 175-188.
18. Wang, J., Xu, Y. Q., Liang, Y. Y., Gongora, R., Warnock, D. G., Ma, H. P. (2007) An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum. Pflugers Arch. 454, 945-956.
19. Villalonga, N., Martinez-Marmol, R., Roura-Ferrer, M., David, M., Valenzuela, C., Soler, C., Felipe, A. (2008) Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim. Biophys. Acta 1783, 728-736.
20. Bielanska, J., Hernandez-Losa, J., Perez-Verdaguer, M., Moline, T., Somoza, R., Ramon, Y. C. S., Condom, E., Ferreres, J. C., Felipe, A. (2009) Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr. Cancer Drug Targets 9, 904-914.
21. Felipe, A., Bielanska, J., Comes, N., Vallejo, A., Roig, S., Ramon, Y. C. S., Condom, E., Hernandez-Losa, J., Ferreres, J. C. (2012) Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. Curr. Med. Chem. 19, 661-674.
22. Arcangeli, A., Crociani, O., Lastraioli, E., Masi, A., Pillozzi, S., Becchetti, A. (2009) Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16, 66-93.
23. Bielanska, J., Hernandez-Losa, J., Moline, T., Somoza, R., Ramon, Y. C. S., Condom, E., Ferreres, J. C., Felipe, A. (2010) Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus. Cell. Physiol. Biochem. 26, 219-226.
24. Castellvi, J., Garcia, A., Ruiz-Marcellan, C., Hernandez-Losa, J., Peg, V., Salcedo, M., Gil-Moreno, A.,Cajal, S. (2009) Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum. Pathol. 40, 1418-1426.
25. Vennekamp, J., Wulff, H., Beeton, C., Calabresi, P. A., Grissmer, S., Hansel, W., Chandy, K. G. (2004) Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 65, 1364-1374.
26. Freedman, B. D., Fleischmann, B. K., Punt, J. A., Gaulton, G., Hashimoto, Y., Kotlikoff, M. I. (1995) Identification of Kv1.1 expression by murine CD4-CD8-thymocytes. A role for voltage-dependent K+ channels in murine thymocyte development. J. Biol. Chem. 270, 22406-22411.
27. Grissmer, S., Ghanshani, S., Dethlefs, B., McPherson, J. D., Wasmuth, J. J., Gutman, G. A., Cahalan, M. D., Chandy, K. G. (1992) The Shawrelated potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells. J. Biol. Chem. 267, 20971-20979.
28. Liu, Q. H., Fleischmann, B. K., Hondowicz, B., Maier, C. C., Turka, L. A., Yui, K., Kotlikoff, M. I., Wells, A. D., Freedman, B. D. (2002) Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J. Exp. Med. 196, 897-909.
29. Vicente, R., Villalonga, N., Calvo, M., Escalada, A., Solsona, C., Soler, C., Tamkun, M. M., Felipe, A. (2008) Kv1.5 association modifies Kv1.3 traffic and membrane localization. J. Biol. Chem. 283, 8756-8764.
30. Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., Karmilowicz, M. J., Auperin, D. D., Chandy, K. G. (1994) Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 45, 1227-1234.
31. Pardo, L. A. (2004) Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19, 285-292.
32. Felipe, A., Vicente, R., Villalonga, N., Roura-Ferrer, M., Martinez-Marmol, R., Sole, L., Ferreres, J. C., Condom, E. (2006) Potassium channels: new targets in cancer therapy. Cancer Detect. Prev. 30, 375-385.
33. Pardo, L. A., Suhmer, W. (2008) Eag1 as a cancer target. Expert Opin. Ther. Targets 12, 837-843.
34. Wonderlin, W. F., Strobl, J. S. (1996) Potassium channels, proliferation and G1 progression. J. Membr. Biol. 154, 91-107.
35. Wulff, H., Castle, N. A., Pardo, L. A. (2009) Voltage-gated potassium channels as therapeutic targets. Nat. Rev. Drug Discov. 8, 982-1001.
36. Conti, M. (2004) Targeting K+ channels for cancer therapy. J. Exp. Ther. Oncol. 4, 161-166.
37. Felipe, A., Snyders, D. J., Deal, K. K., Tamkun, M. M. (1993) Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume. Am. J. Physiol. 265, C1230-C1238.
38. Gelfand, E. W., Or, R. (1991) Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation. J. Immunol. 147, 3452-3458.
39. Abdul, M., Hoosein, N. (2002) Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett. 186, 99-105.
40. Abdul, M., Hoosein, N. (2002) Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 9, 961-964.
41. Abdul, M., Santo, A., Hoosein, N. (2003) Activity of potassium channelblockers in breast cancer. Anticancer Res. 23, 3347-3351.
42. Brevet, M., Fucks, D., Chatelain, D., Regimbeau, J. M., Delcenserie, R., Sevestre, H., Ouadid-Ahidouch, H. (2009) Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 38, 649-654.
43. Brevet, M., Haren, N., Sevestre, H., Merviel, P., Ouadid-Ahidouch, H. (2009) DNA methylation of K(v) 1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma. Cell. Physiol. Biochem. 24, 25-32.
44. Preussat, K., Beetz, C., Schrey, M., Kraft, R., Wolfl, S., Kalff, R., Patt, S. (2003) Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 346, 33-36.
45. Vautier, F., Belachew, S., Chittajallu, R., Gallo, V. (2004) Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation. Glia 48, 337-345.
46. Gulbins, E., Sassi, N., Grassme, H., Zoratti, M., Szabo, I. (2010) Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim. Biophys. Acta 1797, 1251-1259.
47. Storey, N. M., Gomez-Angelats, M., Bortner, C. D., Armstrong, D. L., Cidlowski, J. A. (2003) Stimulation of Kv1.3 potassium channels by death receptors during apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 278, 33319-33326.
48. Szabo, I., Zoratti, M., Gulbins, E. (2010) Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 584, 2049-2056.